miR-155 modifies inflammation, endothelial activation and blood-brain barrier dysfunction in cerebral malaria

Molecular Medicine

Volumn 23, Issue , 2017, Pages 24-33

  Barker, Kevin R ^a,b   Lu, Ziyue ^b   Kim, Hani ^b,h   Zheng, Ying ^c   Chen, Junmei ^d   Conroy, Andrea L ^b,i   Hawkes, Michael ^e   Cheng, Henry S ^a,f   Njock, Makon Sébastien ^f,j   Fish, Jason E ^a,f   Harlan, John M ^g   López, Jose A ^d,g   Conrad Liles, W ^g   Kain, Kevin C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c University of Washington   (United States)

^d Bloodworks Northwest Research Institute   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g UNIVERSITY OF WASHINGTON   (United States)

^h BILL AND MELINDA GATES FOUNDATION   (United States)

ⁱ INDIANA UNIVERSITY   (United States)

^j UNIVERSITY OF LIÈGE   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; CYTOKINE; MICRORNA 155;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD LEVEL; BRAIN DYSFUNCTION; CELL ACTIVATION; CEREBRAL MALARIA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; EX VIVO STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; IMMUNE RESPONSE; MICROVASCULATURE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARASITEMIA; SURVIVAL; WILD TYPE MOUSE;

EID: 85014351357     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2016.00139     Document Type: Article

References (58)

1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 388:1545-1602.
2. Wang H, et al. (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 388:1459-1544.
3. Dondorp AM, et al. (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 376:1647-57.
4. Dondorp A, Nosten F, Stepniewska K, Day N, White N. (2010) Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 366:717-25.
5. Kim H, Higgins S, Liles WC, Kain KC. (2011) Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics. Curr. Opin. Hematol. 18:177-85.
6. Miller LH, Ackerman HC, Su X, Wellems TE. (2013) Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. 19:156-67.
7. Lee WL, Liles WC (2011) Endothelial activation, dysfunction and permeability during severe infections. Curr. Opin. Hematol. 18:191-6.
8. Page A V, Liles WC (2013) Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence. 4:507-16.
9. Serghides L, et al. (2011) Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria. PLoS One. 6:e27714.
10. Yeo TW, et al. (2008) Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc. Natl. Acad. Sci. USA. 105:17097-102.
11. Erdman LK, et al. (2011) Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One. 6:e17440.
12. Hughes DP, Marron MB, Brindle NPJ. (2003) The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2. Circ. Res. 92:630-36.
13. Kim I, et al. (2001) Vascular endothelial growth factor expression of intercellular adhesion mole­cule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J. Biol. Chem. 276:7614-20.
14. Gavard J, Patel V, Gutkind JS. (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell. 14:25-36.
15. Kontos CD, Cha EH, York JD, Peters KG. (2002) The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol. Cell. Biol. 22: 1704-13.
16. Fiedler U, et al. (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat. Med. 12:235-9.
17. Parikh SM, et al. (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 3:e46.
18. Engels BM, Hutvagner G. (2006) Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 25:6163-9.
19. Cannella D, et al. (2014) miR-146a and miR-155 delineate a MicroRNA fingerprint associated with Toxoplasma persistence in the host brain. Cell Rep. 6:928-37.
20. Lopez-Ramirez MA, et al. (2014) MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J. 28:2551-65.
21. Rodriguez A, et al. (2007) Requirement of bic/ microRNA-155 for normal immune function. Science. 316:608-11.
22. Finney CA, et al. (2011) S1P is associated with protection in human and experimental cerebral malaria. Mol. Med. 17:717-25.
23. Njock M-S, et al. (2015) Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing anti-inflammatory microRNAs. Blood. 125:3202-12.
24. Vandesompele J, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034.
25. Cheng HS, et al. (2013) MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol. Med. 5:949-66.
26. Hawkes MT, et al. (2015) Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial. Malar. J. 14:421.
27. Zheng Y, et al. (2012) In vitro microvessels for the study of angiogenesis and thrombosis. Proc. Natl. Acad. Sci. USA. 109:9342-7.
28. Min-Oo G, et al. (2003) Pyruvate kinase deficiency in mice protects against malaria. Nat. Genet. 35:357-62.
29. Ayi K, et al. (2008) Pyruvate kinase deficiency and malaria. N. Engl. J. Med. 358:1805-10.
30. Patel SN, et al. (2008) C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J. Exp. Med. 205:1133-43.
31. Turner GD, et al. (1994) An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am. J. Pathol. 145:1057-69.
32. Conroy AL, et al. (2010) Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study. PLoS One. 5:e15291.
33. Grau GE, et al. (1989) Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320:1586-91.
34. Krützfeldt J, et al. (2005) Silencing of microRNAs in vivo with “antagomirs.” Nature. 438:685-9.
35. Brown H, et al. (2001) Blood-brain barrier function in cerebral malaria in Malawian children. Am. J. Trop. Med. Hyg. 64:207-13.
36. Seydel KB, et al. (2015) Brain swelling and death in children with cerebral malaria. N. Engl. J. Med. 372:1126-37.
37. Broermann A, et al. (2011) Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. J. Exp. Med. 208:2393-401.
38. Creemers EE, Tijsen AJ, Pinto YM. (2012) Circulating MicroRNAs: Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease? Circ. Res. 110:483-95.
39. Singh R, Pochampally R, Watabe K, Lu Z, Mo Y-Y. (2014) Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol. Cancer. 13:256.
40. Alexander M, et al. (2015) Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nat. Commun. 6:7321.
41. Higgins SJ, Silver KL, Liles WC, Kain KC. (2013) Investigating the Angiopoeitin-tie2 Pathway as a Therapeutic Target to Improve Survival Following Experimental Life-Threatening Plasmodium Challenge [Abstract 1015]. In: The American Journal of Tropical Medicine and Hygiene 62nd Annual Meeting Abstract Book. Washington, DC. 89:308.
42. Lovegrove FE, et al. (2009) Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One. 4:e4912.
43. Pamplona A, et al. (2007) Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 13:703-10.
44. Walther M, et al. (2012) HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children. PLoS Pathog. 8:e1002579.
45. Serghides L, et al. (2014) PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria. PLoS Pathog. 10:e1003980.
46. Linares M, et al. (2013) Glutathione peroxidase contributes with heme oxygenase-1 to redox balance in mouse brain during the course of cerebral malaria. Biochim. Biophys. Acta. 1832: 2009-18.
47. Kitamuro T, et al. (2003) Bach1 Functions as a Hypoxia-inducible Repressor for the Heme Oxygenase-1 Gene in Human Cells. J. Biol. Chem. 278:9125-33.
48. Davudian S, Mansoori B, Shajari N, Mohammadi A, Baradaran B. (2016) BACH1, the master regulator gene: A novel candidate target for cancer therapy. Gene. 588:30-7.
49. Pulkkinen KH, Ylä-Herttuala S, Levonen A-L. (2011) Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells. Free Radic. Biol. Med. 51:2124-31.
50. Cheng HS, Njock M-S, Khyzha N, Dang LT, Fish JE. (2014) Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation. Front. Genet. 5:422.
51. Baumjohann D, Ansel KM. (2013) MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat. Rev. Immunol. 13:666-78.
52. Gracias DT, et al. (2013) The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nat. Immunol. 14:593-602.
53. Seddiki N, Brezar V, Ruffin N, Lévy Y, Swaminathan S. (2014) Role of miR-155 in the regulation of lymphocyte immune function and disease. Immunology. 142:32-8.
54. Howland SW, Claser C, Poh CM, Gun SY, Rénia L. (2015) Pathogenic CD8+ T cells in experimental cerebral malaria. Semin. Immunopathol. 37:221-31.
55. Poh CM, Howland SW, Grotenbreg GM, Rénia L. (2014) Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities. Infect. Immun. 82:4854-64.
56. Guermonprez P, et al. (2013) Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat. Med. 19:730-8.
57. Gordon EB, et al. (2015) Inhibiting the mammalian target of rapamycin blocks the development of experimental cerebral malaria. MBio. 6:e00725.
58. Conroy AL, et al. (2012) Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria. Crit. Care Med. 40:952-9.